Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Trazzi

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Human Molecular Genetics|January 27, 2011
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndromeStefania Trazzi, Valentina Maria Mitrugno, Emanuele Valli, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndromePatrizia Bianchi, Elisabetta Ciani, Sandra Guidi, et al.
Brain Pathology (Zurich, Switzerland)|July 24, 2012
Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndromeSandra Guidi, Fiorenza Stagni, Patrizia Bianchi, et al.
Experimental Cell Research|July 10, 2007
Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activitiesDaniel Diolaiti, Roberto Bernardoni, Stefania Trazzi, et al.
Neurobiology of Disease|June 22, 2014
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signalingClaudia Fuchs, Stefania Trazzi, Roberta Torricella, et al.
Biomolecules|September 28, 2023
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderNicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
International Journal of Molecular Sciences|July 29, 2025
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in MiceNicola Mottolese, Feliciana Iannibelli, Giulia Candini, et al.
International Journal of Molecular Sciences|August 12, 2022
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency DisorderMarianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.
Neuropharmacology|August 31, 2019
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorderClaudia Fuchs, Laura Gennaccaro, Elisa Ren, et al.
Neurobiology of Disease|May 10, 2023
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorderMarianna Tassinari, Beatrice Uguagliati, Stefania Trazzi, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Human Molecular Genetics|January 27, 2011
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndromeStefania Trazzi, Valentina Maria Mitrugno, Emanuele Valli, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndromePatrizia Bianchi, Elisabetta Ciani, Sandra Guidi, et al.
Brain Pathology (Zurich, Switzerland)|July 24, 2012
Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndromeSandra Guidi, Fiorenza Stagni, Patrizia Bianchi, et al.
Experimental Cell Research|July 10, 2007
Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activitiesDaniel Diolaiti, Roberto Bernardoni, Stefania Trazzi, et al.
Neurobiology of Disease|June 22, 2014
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signalingClaudia Fuchs, Stefania Trazzi, Roberta Torricella, et al.
Biomolecules|September 28, 2023
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderNicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
International Journal of Molecular Sciences|July 29, 2025
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in MiceNicola Mottolese, Feliciana Iannibelli, Giulia Candini, et al.
International Journal of Molecular Sciences|August 12, 2022
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency DisorderMarianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.
Neuropharmacology|August 31, 2019
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorderClaudia Fuchs, Laura Gennaccaro, Elisa Ren, et al.
Neurobiology of Disease|May 10, 2023
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorderMarianna Tassinari, Beatrice Uguagliati, Stefania Trazzi, et al.
Pageof 5